News Announcement

Strides Pharma Science: Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31 2021

The Board of Directors at their meeting held today i.e. on May 27 2021 has inter-alia approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2021.

In this regard please find enclosed the following:

1. A copy of the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31 2021 along with Auditors Report for the said period;

2. Declaration on Unmodified Opinion in the Auditors Report for Financial Year ended March 31 2021; and

3. Press Release tilted Strides reports strong FY21 performance with 29% revenue and 67% EBITDA growth.

The Board Meeting commenced at 11:45 hrs and concluded at 13:15 hrs.

This is for your information and record.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.